Arcadia Biosciences’ CEO attempts his third turnaround

Sacramento Business Journal

View Source

Arcadia Biosciences Inc. CEO Matt Plavan is choreographing a major pivot for the publicly traded seed company, transitioning from developing fringe products to developing products in growth sectors such as wheat and commercial hemp.

It is a familiar situation for Plavan, as he’s helped lead pivots at local public companies twice before.